Primary study · included by 1 review
The effect of ketorolac buccal infiltration on postoperative endodontic pain: a prospective, double-blind, randomized, controlled clinical trial.
Akhlaghi 2019 · Akhlaghi Nahid, Azarshab Mahsa, Akhoundi Nasrin, et al. · Quintessence international (Berlin, Germany : 1985) · 2019
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Patients requiring additional (rescue) medication Ketorolac (oral, intramuscular, intranasal, periapical or intracanal) vs Other analgesics or placebo (dexamethasone, ibuprofen, tapentadol, etodolac, prednisolone, saline) · after root canal treatment | RR 0.50 [0.35, 0.73] | 3 studies · 212 participants | GRADE not reported |
Post-endodontic pain intensity Ketorolac (oral, intramuscular, intranasal, periapical or intracanal) vs Other analgesics or placebo (dexamethasone, ibuprofen, tapentadol, etodolac, prednisolone, saline) · 24 h after root canal treatment | SMD -0.25 [-1.07, 0.56] | 3 studies · 250 participants | GRADE not reported |
Post-endodontic pain intensity Ketorolac (oral, intramuscular, intranasal, periapical or intracanal) vs Other analgesics or placebo (dexamethasone, ibuprofen, tapentadol, etodolac, prednisolone, saline) · 6 h after root canal treatment | SMD -0.82 [-1.18, -0.46] | 3 studies · 250 participants | GRADE not reported |
1 including review in total.